Literature DB >> 21468037

Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma.

P Kapoor, S Kumar, S J Mandrekar, K M Laumann, A Dispenzieri, M Q Lacy, D Dingli, M A Gertz, R A Kyle, P R Greipp, S V Rajkumar, T E Witzig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21468037     DOI： 10.1038/leu.2011.54

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

Review 1.  Update on risk stratification and treatment of newly diagnosed multiple myeloma.

Authors:  Prashant Kapoor; S Vincent Rajkumar
Journal:  Int J Hematol       Date:  2011-10-18       Impact factor: 2.490

2.  A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).

Authors:  Barbara Kiesewetter; Marlene Troch; Werner Dolak; Leonhard Müllauer; Julius Lukas; Christoph C Zielinski; Markus Raderer
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.